Variant report
Variant | esv3376643 |
---|---|
Chromosome Location | chr10:56933114-56933399 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs552610587 | chr10:56933120-56933121 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs369147293 | chr10:56933125-56933126 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs371490699 | chr10:56933140-56933141 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs529065466 | chr10:56933153-56933154 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs72801679 | chr10:56933173-56933174 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs568407429 | chr10:56933177-56933178 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs534065332 | chr10:56933186-56933187 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs565611125 | chr10:56933197-56933198 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs553832028 | chr10:56933249-56933250 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs372128400 | chr10:56933262-56933263 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs12572873 | chr10:56933271-56933272 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs183625551 | chr10:56933319-56933320 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs556181701 | chr10:56933324-56933325 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs575751664 | chr10:56933339-56933340 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs376986202 | chr10:56933343-56933344 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs561137052 | chr10:56933357-56933358 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs144088113 | chr10:56933360-56933361 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs544778936 | chr10:56933374-56933375 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs188562982 | chr10:56933379-56933380 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 18414403 | CNVD |
Cockayne syndrome | 18421352 | CNVD |
Glioblastoma | 16823260 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neuroblastoma | 17533364 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Glioma | 21971842 | CNVD |
Cancer | 21637783 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Obesity | 21956041 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Autism | 20841430 | CNVD |
Mental retardation | 17124404 | CNVD |
Epilepsy | 20923578 | CNVD |
Prostate cancer | 16573809 | CNVD |
Schizophrenia | 19329560 | CNVD |
Heart failure | 18772530 | CNVD |
Heart failure | 18854381 | CNVD |
Hyperglycemia | 19060297 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Usher syndrome | 20538994 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Autism | 20858243 | CNVD |
Breast cancer | 22522925 | CNVD |
Usher type I cohort | 17277737 | CNVD |
Usher type I cohort | 21436283 | CNVD |
Leukemia | 21357790 | CNVD |
Medulloblastoma | 22832581 | CNVD |
small cell lung cancer | 17426248 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:56932200-56933200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
2 | chr10:56932800-56934000 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
3 | chr10:56933000-56934000 | Weak transcription | H1 Cell Line | embryonic stem cell |
4 | chr10:56933000-56934000 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
5 | chr10:56933000-56934000 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
6 | chr10:56933000-56934400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
7 | chr10:56933200-56933600 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |